BRNS - Barinthus Biotherapeutics Plc. - ADR
IEX Last Trade
1.315
0.035 2.662%
Share volume: 2,722
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.28
0.04
2.73%
Summary score
18%
Profitability
15%
Dept financing
3%
Liquidity
75%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-5.11%
Return on assets
-4.91%
Return on sales
157399.24%
Return on invested capital
18.8%
Total debt ratio
10.35%
Debt ratio change over timeo
-0.96%
Current Ratio
18.33%
Quick Ratio
18.33%
Cash Position Ratio
16.99%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-9.11%
Return on assets
-8.88%
Return on sales
-7885.33%
Return on invested capital
-39.31%
Total debt ratio
13.39%
Debt ratio change over timeo
-1.25%
Current Ratio
12.02%
Quick Ratio
12.02%
Cash Position Ratio
11.08%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-9.01%
Return on assets
-8.48%
Return on sales
0%
Return on invested capital
-35.59%
Total debt ratio
13.86%
Debt ratio change over time
-1.36%
Current Ratio
11.15%
Quick Ratio
11.15%
Cash Position Ratio
10.13%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-95.07%
Return on assets
-95.28%
Return on sales
2510716.16%
Return on invested capital
-78.11%
Total debt ratio
-96.12%
Debt ratio change over time
-0.96%
Current Ratio
6.12%
Quick Ratio
6.12%
Cash Position Ratio
5.09%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BRNS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -5.11% | 13.79% | 34.47% | 7.43% |
| Return on assets | -4.91% | 2.76% | 3.15% | 5.62% |
| Return on sales | 157399.24% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 18.8% | 2.36% | 5.39% | 19.77% |
| Profitability | 49% | 25% | 46% | 55% |
| Total debt ratio | 10.35% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.96% | 308.97% | -6.99% | 1.18% |
| Dept financing | 3% | 50% | 25% | 7% |
| Current Ratio | 12.02% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 12.02% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 11.08% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 3% | 6% | 14% |
| Short-term ratios | BRNS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -9.11% | 13.77% | 13.25% | 3.8% |
| Return on assets | -8.88% | 2.43% | 1.89% | 3.09% |
| Return on sales | -7885.33% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -39.31% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 13.39% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -1.25% | 46.38% | -72.08% | 1.51% |
| Dept financing | 4% | 50% | 25% | 7% |
| Current Ratio | 12.02% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 12.02% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 11.08% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 4% | 11% | 27% |